Stocktoria
Nautilus Biotechnology, Inc. NAUT
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2020-08-07
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Net income | -$59.0M | -$70.8M | -$63.7M | -$57.9M | -$50.3M |
| Operating cash flow | -$50.7M | -$59.1M | -$51.7M | -$45.8M | -$39.2M |
| Free cash flow | -$52.0M | -$61.3M | -$54.2M | -$48.1M | -$41.5M |
| Total assets | $191.1M | $242.7M | $305.6M | $350.1M | $398.4M |
| Total liabilities | $34.1M | $34.0M | $40.2M | $35.1M | $34.9M |
| Shareholders' equity | $157.0M | $208.7M | $265.4M | $314.9M | $363.6M |
| Ratios | |||||
| Return on assets | -30.9% | -29.2% | -20.8% | -16.5% | -12.6% |
| Return on equity | -37.6% | -33.9% | -24.0% | -18.4% | -13.8% |
| Current ratio | 13.33 | 17.40 | 19.39 | 27.57 | 60.09 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 265,700 | $1.0M |
| Point72 Asset Management, L.P. | 83,043 | $322,207 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001808805 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.